How medicines, medical devices and clinical trials would be regulated if there’s no Brexit deal

Register and reap the benefits

Become a member of the HCSA to gain access to a variety of support tools and services.

Join us

Winter Conference 2021 Countdown


HCSA Job Board

All the latest NHS procurement job opportunities

See the latest jobs..

Guidance

How medicines, medical devices and clinical trials would be regulated if there’s no Brexit deal

Continuing human medicine, device and clinical trial regulation in the UK if we leave the EU with ‘no deal’.

Documents

Details

If the UK leaves the EU in March 2019 with ‘no deal’, this would affect the regulation of:

  • medicines
  • medical devices
  • clinical trials

We have published an updated guidance note, which is in response to a consultation on a no-deal scenario.

 

Published 23 August 2018
Last updated 3 January 2019 — see all updates